Research & Clinical Summary

Dr. Meshinchi’s laboratory is focused on the identification and functional evaluation of molecular alterations in leukemias, in order to advance novel “biomarkers” for clinical risk assessment and to be used as therapeutic targets. He is recognized worldwide as an expert in large-scale studies of the many genes (the genome), “RNA” molecules that are made from genes (the transcriptome), and small chemical changes that can substantially change gene, RNA and protein activities (the epigenome) to promote leukemia formation and progression.

Publications

More publications associated with this author on PubMed

The following publications were retrieved from PubMed:

2049Meshinchi, Soheil

More publications associated with this author on PubMed